Australian healthcare stocks rise as Bell Potter sees most cos unfazed by potential tariffs

Index of Australian Healthcare stocks .AXHJ rises 1.9%, tracking broadly positive market sentiment .AX

Bell Potter says that most healthcare firms remain unaffected from tariff impacts, but Nanosonics NAN.AX, Aroa ARX.AX, and Trajan TRJ.AX, which generate significant U.S. sales from international medical devices/equipment, may be susceptible

Neuren NEU.AX, Clarity CU6.AX and Polynovo PNV.AX are among the top gainers on the sub-index, up 20%, 6.7% and 6.3% respectively

Brokerage expects some impact on country's biggest pharma co CSL CSL.AX given fractionation of its unit's plasma-derived products across Australia, Germany, Switzerland and the U.S.

Adds, tariffs could impact pharma cos, but lack of details complicates potential impact assessment

Sub-index down 12.2% YTD, compared to 5% drop in benchmark ASX 200 .AXJO